Co-Amoxiclav
Co-amoxiclav is a combination of Amoxicillin and Potassium Clavulanate (clavulanic acid) indicated in the treatment of infections due to susceptible isolates of the designated bacteria.
- LRTIs such as tonsillitis and sinusitis.
- Otitis media.
- URTIs such as broncho and lobar-pneumonia, acute and chronic bronchitis.
- UTIs such as female genital infections, cystitis, urethritis and pyelonephritis.
- Skin and soft tissue infections.
- Pre and post-operative infections.
- Gonorrheal infections.
High clearance rate of bacteria load.
Rapidly effective.
Cost-effective.
Reduces the chance of relapse.
High cure rate.
Affordable to patient.
Directions
Co-amoxiclav 1g: 1 table twice daily.
Co-amoxiclav 625mg: 1 tablet twice daily.
Co-amoxiclav 228.5ml: Depends on body weight.
